SOPHARMA (SPH): Sopharma monthly March 2017 - raport 14
Raport ESPI
UNI - EN REPORT No14/2017
For the first quarter of this year, revenues from sales increased by 12% compared to the same period of 2016, including 4% decrease of domestic sales and 24% increase of export sales.
"Sales on the Russian market in March reassert the uptrend since the beginning of the year and are a real indicator of improving the economic situation. At present, our forecast are that export sales will grow also over the next few months.", said Ognian Donev, PhD, Executive Director and Chairman of the Board of Directors of "Sopharma" AD.
